마취영역에서 isobole과 response surface model을 이용한 약제의 상호작용 고찰 = An overview of pharmacodynamic drug interaction with isobole and response surface model in anesthesia

다국어 초록 (Multilingual Abstract)

Drug interaction is the principal concept of anesthetic practice. Typically, drug interactions are divided into three categories i.e., additive, synergistic, or infra-additive interactions. Pharmacodynamic drug interactions are typically described using mathematical models. The traditional model is an isobole, which is an iso-effect curve that shows dose or concentration combinations that result in equal effect. Response surface model is a pharmacodynamic tool that describes all isoboles and concentration effect curves for a given endpoint in one equation. In summarizing concentration-effect relationships, the response surface model allows anesthesiologists the versatility to work with precise and safe drug interactions. The aim of this review is to provide the reader with principal concepts of the isobole and response surface model and evaluate characteristics of most commonly used models, including 4 response surface models i.e., the Greco model, reduced Greco model, Minto model, and the Hierarchy model. In addition, the concept of population analysis using nonlinear mixed effects modeling is introduced.

참고문헌 (Reference)

1 Greco WR, "The search for synergy : a critical review from a response surface perspective" 47 : 331-385, 1995

2 Heyse B, "Sevoflurane remifentanil interaction : comparison of different response surface models" 116 : 311-323, 2012

3 Liou JY, "Response surface models in the field of anesthesia : A crash course" 53 : 139-145, 2015

4 Nieuwenhuijs DJ, "Response surface modeling of remifentanilpropofol interaction on cardiorespiratory control and bispectral index" 98 : 312-322, 2003

5 Ting CK, "Response surface model predictions of wake-up time during scoliosis surgery" 118 : 546-553, 2014

6 Minto CF, "Response surface model for anesthetic drug interactions" 92 : 1603-1616, 2000

7 Wang HL, "Response surface analysis of sevoflurane-remifentanil interactions on consciousness during anesthesia" 125 : 2682-2687, 2012

8 Bi SS, "Remifentanil-sevoflurane interaction models of circulatory response to laryngoscopy and circulatory depression" 110 : 729-740, 2013

9 Egan TD, "Remifentanil versus alfentanil : comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers" 84 : 821-833, 1996

10 Mertens MJ, "Propofol reduces perioperative remifentanil requirements in a synergistic manner : response surface modeling of perioperative remifentanil-propofol interactions" 99 : 347-359, 2003

11 Shafer SL, "Pharmacokinetics, pharmacodynamics, and rational opioid selection" 74 : 53-63, 1991

12 Bouillon TW, "Pharmacodynamic interaction between propofol and remifentanil regarding hypnosis, tolerance of laryngoscopy, bispectral index, and electroencephalographic approximate entropy" 100 : 1353-1372, 2004

13 Manyam SC, "Opioid-volatile anesthetic synergy : a response surface model with remifentanil and sevoflurane as prototypes" 105 : 267-278, 2006

14 Luginbuhl M, "Noxious stimulation response index : a novel anesthetic state index based on hypnotic-opioid interaction" 112 : 872-880, 2010

15 McEwan AI, "Isoflurane minimum alveolar concentration reduction by fentanyl" 78 : 864-869, 1993

16 Hendrickx JF, "Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility" 107 : 494-506, 2008

17 Kissin I, "General anesthetic action: an obsolete notion?" 76 : 215-218, 1993

18 Short TG, "Efficient trial design for eliciting a pharmacokinetic-pharmacodynamic model-based response surface describing the interaction between two intravenous anesthetic drugs" 96 : 400-408, 2002

19 Glass PS, "Drug interactions:volatile anesthetics and opioids" 9 (9): S18-S22, 1997

20 이수일, "Drug interaction: focusing on response surface models" 대한마취통증의학회 58 (58): 421-434, 2010

21 Chou TC, "Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands" 59 : 253-276, 1976

22 Glass PS, "Anesthetic drug interactions : an insight into general anesthesia--its mechanism and dosing strategies" 88 : 5-6, 1998

23 LaPierre CD, "An exploration of remifentanil-propofol combinations that lead to a loss of response to esophageal instrumentation, a loss of responsiveness, and/or onset of intolerable ventilatory depression" 113 : 490-499, 2011

24 Johnson KB, "An evaluation of remifentanil propofol response surfaces for loss of responsiveness, loss of response to surrogates of painful stimuli and laryngoscopy in patients undergoing elective surgery" 106 : 471-479, 2008

25 LaPierre CD, "A simulation study of common propofol and propofol-opioid dosing regimens for upper endoscopy : implications on the time course of recovery" 117 : 252-262, 2012

26 Heyse B, "A response surface model approach for continuous measures of hypnotic and analgesic effect during sevoflurane-remifentanil interaction : quantifying the pharmacodynamic shift evoked by stimulation" 120 : 1390-1399, 2014

27 Kern SE, "A response surface analysis of propofol-remifentanil pharmacodynamic interaction in volunteers" 100 : 1373-1381, 2004